These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7326104)

  • 1. [Natural killer activity in patients with malignant melanoma].
    Masserini C; Villa ML; Rovini D; Clerici E
    Boll Ist Sieroter Milan; 1981; 60(4):307-15. PubMed ID: 7326104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients.
    Hersey P; Hobbs A; Edwards A; McCarthy WH; McGovern VJ
    Cancer Res; 1982 Jan; 42(1):363-8. PubMed ID: 7053864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy.
    Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma.
    Gamaleia NF; Skivka LM; Fedorchuk AG; Shishko ED
    Exp Oncol; 2006 Mar; 28(1):54-60. PubMed ID: 16614709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
    Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
    Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies].
    Graul A; Orfanos CE
    Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.
    Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC
    Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
    Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
    Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
    Allavena P; Introna M; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: melanoma, carcinoma, chronic and acute lymphatic leukemia].
    Gabrilovac J
    Lijec Vjesn; 1985 Aug; 107(8):323-6. PubMed ID: 3864002
    [No Abstract]   [Full Text] [Related]  

  • 14. Human natural killer cells: a comprehensive review.
    Sinkovics JG; Horvath JC
    Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for an association between natural killer cell activity and prognosis in melanoma patients.
    Hersey P; Edwards A; Milton GW; McCarthy WH
    Nat Immun Cell Growth Regul; 1983-1984; 3(2):87-94. PubMed ID: 6679887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
    Kristensen E
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural killer (NK) activity of the peripheral blood lymphocytes in cancer patients].
    Song Y
    Zhonghua Wai Ke Za Zhi; 1989 Jun; 27(6):357-8, 381-2. PubMed ID: 2479505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
    Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
    J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
    Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.